These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 11177311

  • 1. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA.
    Ann Intern Med; 2001 Jan 16; 134(2):89-95. PubMed ID: 11177311
    [Abstract] [Full Text] [Related]

  • 2. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU, Broomé U, Persson B.
    Dis Colon Rectum; 2001 Jan 16; 44(1):77-85. PubMed ID: 11805567
    [Abstract] [Full Text] [Related]

  • 3. Prevention of colon cancer with ursodiol in ulcerative colitis.
    Kim HS.
    Inflamm Bowel Dis; 2001 Aug 16; 7(3):279-80. PubMed ID: 11515858
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ursodiol for all?
    Lee SD, Surawicz CM.
    Am J Gastroenterol; 2001 Dec 16; 96(12):3437-8. PubMed ID: 11774966
    [No Abstract] [Full Text] [Related]

  • 6. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
    Pardi DS, Loftus EV, Kremers WK, Keach J, Lindor KD.
    Gastroenterology; 2003 Apr 16; 124(4):889-93. PubMed ID: 12671884
    [Abstract] [Full Text] [Related]

  • 7. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
    Wolf JM, Rybicki LA, Lashner BA.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):783-8. PubMed ID: 16225486
    [Abstract] [Full Text] [Related]

  • 8. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Gurbuz AK, Giardiello FM, Bayless TM.
    Dis Colon Rectum; 1995 Jan 01; 38(1):37-41. PubMed ID: 7813342
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec 01; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 11. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Bennett AE, Rizk M, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 01; 7(12):974-81. PubMed ID: 23523416
    [Abstract] [Full Text] [Related]

  • 12. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD.
    Am J Gastroenterol; 2011 Sep 01; 106(9):1638-45. PubMed ID: 21556038
    [Abstract] [Full Text] [Related]

  • 13. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
    Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO.
    Gastrointest Endosc; 2002 Jul 01; 56(1):48-54. PubMed ID: 12085034
    [Abstract] [Full Text] [Related]

  • 14. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
    Aitola P, Mattila J, Matikainen M.
    Int J Colorectal Dis; 2000 Jun 01; 15(3):167-71. PubMed ID: 10954188
    [Abstract] [Full Text] [Related]

  • 15. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 01; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 01; 7(12):e684-91. PubMed ID: 23916526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ulcerative colitis and an abnormal cholangiogram.
    Nguyen DL, Lazaridis KN.
    Cleve Clin J Med; 2011 May 01; 78(5):306-11. PubMed ID: 21536825
    [No Abstract] [Full Text] [Related]

  • 20. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
    Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, zum Büschenfelde KH, Lohse AW.
    Ann Intern Med; 1999 Dec 21; 131(12):943-6. PubMed ID: 10610645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.